SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Weiss SW, Goldblum JR. Enzinger and Weiss's soft tissue pathology, 4th edition. St. Louis: Mosby, 2001.
  • 2
    BeahrsOH, HensonDE, HutterRVP, et al., editors. Manual for staging of cancer, 3rd edition. Philadelphia: Lippincott, 1992.
  • 3
    Enneking WF, Spanier SS, Goodman MA. A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop. 1980; 153: 106.
  • 4
    Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958; 53: 457481.
  • 5
    Cox D. Regression models and life tables (with discussion). J R Stat Soc B. 1972; 34: 187220.
  • 6
    Grambsch P, Therneau T. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika. 1994; 81: 515526.
  • 7
    O'Brien JE, Stout AP. Malignant fibrous xanthomas. Cancer Metastasis Rev. 1964; 17: 14451456.
  • 8
    Schurch W, Begin LR, Seemayer TA, et al. Pleomorphic soft tissue myogenic sarcomas of adulthood. A reappraisal in the mid-1990s. Am J Surg Pathol. 1996; 20: 131147.
  • 9
    Weiss SW, Enzinger FM. Malignant fibrous histiocytoma: an analysis of 200 cases. Cancer. 1978; 41: 22502266.
  • 10
    Weiss SW. Malignant fibrous histiocytoma. A reaffirmation. Am J Surg Pathol. 1982; 6: 773784.
  • 11
    Fletcher CD. Pleomorphic malignant fibrous histiocytoma: fact or fiction? A critical reappraisal based on 159 tumors diagnosed as pleomorphic sarcoma. [see comment]. Am J Surg Pathol. 1992; 16: 213228. Comments in: Am J Surg Pathol. 1992;16:1023–1024; Am J Surg Pathol. 1993;17:422–423.
  • 12
    Fletcher CD, Gustafson P, Rydholm A, Willen H, Akerman M. Clinicopathologic re-evaluation of 100 malignant fibrous histiocytomas: prognostic relevance of subclassification. J Clin Oncol. 2001; 19: 30453050.
  • 13
    Hashimoto H, Daimaru Y, Takeshita S, Tsuneyoshi M, Enjoji M. Prognostic significance of histologic parameters of soft tissue sarcomas. Cancer. 1992; 70: 28162822.
  • 14
    Coindre JM, Terrier P, Guillou L, et al. Predictive value of grade for metastasis development in the main histologic types of adult soft tissue sarcomas: a study of 1240 patients from the French Federation of Cancer Centers Sarcoma Group. Cancer. 2001; 91: 19141926.
  • 15
    Pisters PW, Leung DH, Woodruff J, Shi W, Brennan MF. Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol. 1996; 14: 16791689.
  • 16
    Chen CM, Chen CJ, Chang CL, Shyu JS, Hsieh HF, Harn HJ. CD34, CD117, and actin expression in phyllodes tumor of the breast. J Surg Res. 2000; 94: 8491.
  • 17
    Banerjee SS, Bishop PW, Nicholson CM, Eyden BP. Malignant melanoma showing smooth muscle differentiation. J Clin Pathol. 1996; 49: 950951.
  • 18
    Banerjee S, Agbamu D, Eyden B, Harris M. Clinicopathological characteristics of peripheral primitive neuroectodermal tumour of skin and subcutaneous tissue. Histopathology. 1997; 31: 355366.
    Direct Link:
  • 19
    Gebhard S, Coindre JM, Michels JJ, et al. Pleomorphic liposarcoma: clinicopathologic, immunohistochemical, and follow-up analysis of 63 cases: a study from the French Federation of Cancer Centers Sarcoma Group. Am J Surg Pathol. 2002; 26: 601616.
  • 20
    Gibas Z, Miettinen M, Limon J, et al. Cytogenetic and immunohistochemical profile of myxoid liposarcoma. Am J Clin Pathol. 1995; 103: 2026.
  • 21
    Oda Y, Miyajima K, Kawaguchi K, et al. Pleomorphic leiomyosarcoma: clinicopathologic and immunohistochemical study with special emphasis on its distinction from ordinary leiomyosarcoma and malignant fibrous histiocytoma. [see comment]. Am J Surg Pathol. 2001; 25: 10301038. Comment in: Am J Surg Pathol. 2002;26:393–394; discussion 394–396.
  • 22
    Furlong MA, Mentzel T, Fanburg-Smith JC. Pleomorphic rhabdomyosarcoma in adults: a clinicopathologic study of 38 cases with emphasis on morphologic variants and recent skeletal muscle-specific markers. Mod Pathol. 2001; 14: 595603.
  • 23
    Hasegawa T, Yamamoto S, Nojima T, et al. Validity and reproducibility of histologic diagnosis and grading for adult soft-tissue sarcomas. Hum Pathol. 2002; 33: 111115.
  • 24
    Singer S, Corson JM, Gonin R, Labow B, Eberlein TJ. Prognostic factors predictive of survival and local recurrence for extremity soft tissue sarcoma [see comment]. Ann Surg. 1994; 219: 165173. Comment in: Ann Surg. 1995;221:203–205.
  • 25
    Bieche I, Lazar V, Nogues C, et al. Prognostic value of chorionic gonadotropin beta gene transcripts in human breast carcinoma. Clin Cancer Res. 1998; 4: 671676.
  • 26
    Mertens F, Stromberg U, Mandahl N, et al. Prognostically important chromosomal aberrations in soft tissue sarcomas: a report of the Chromosomes and Morphology (CHAMP) Study Group. Cancer Res. 2002; 62: 39803984.